Coronavirus: Remdesivir does not prevent deaths, says WHO trial
Share article:
Share article:

Coronavirus: Remdesivir does not prevent deaths, says WHO trial

© Belga

The anti-viral medication remdesivir has no significant effect in preventing the deaths of Covid-19 patients, according to a multinational study carried out by the World Health Organisation (WHO).

The study involved 11,000 test subjects in 30 countries worldwide. The results, published by the WHO yesterday, consist only of raw data, which have not yet been peer-reviewed or published in a journal. They have already led to some dispute.

Remdesivir is a medication developed by the pharmaceutical company Gilead for the treatment of Ebola virus and hepatitis C, and was thought to show promise in the treatment of Covid-19.

It was later thought to reduce the time Covid-19 patients spent in recovery. Earlier this month, it was part of a cocktail of drugs administered to US president Donald Trump, which allowed him to make an unusually speedy recovery from a Covid infection.

Barely a week ago, an analysis published in the New England Journal of Medicine suggested “a trend towards reduced mortality” in some patients. Now the WHO study has put paid to that hope.

The so-called Solidarity study involved 11,300 patients in 405 hospitals in 30 countries, who were administered one or more drugs either singly or in combination – remdesivir, hydroxychloroquine, lopinavir (used in treatment of HIV), interferon (used in treating cancers and viral infections) or interferon plus lopinavir.

A control group of 4,100 patients received no medication.

In the end, the results showed no effect on the time spent in hospital, the chances of requiring a ventilator or the rate of mortality, the WHO said. The authors of the study called the results “unpromising”.

The most serious effects of a Covid-19 infection are thought to be caused not by the virus itself, but by what is known as a cytokine storm, when the immune system reacts massively to the infection, turning the body’s defences against itself.

Even if the antiviral has no effect by the time that event occurs, the hope is now that a drug like remdesivir could still have some effect in the early stages by preventing the cytokine storm from taking place.

The European Commission, acting on behalf of member states, recently negotiated the purchase of 500,000 treatment of remdesivir, and the drug, costing some $2,300 a time, is used in Belgian hospitals to treat severe cases of Covid-19.

Alan Hope
The Brussels Times

Latest news

Flanders introduces ‘invisible’ speed cameras
New digital speed cameras that are essentially invisible to the road user are being introduced on various roads and motorways in Flanders, Flemish ...
Warnings issued for slippery roads across Belgium
Drivers have been asked to watch out for slippery roads from Saturday afternoon until Sunday evening, as snow and cold temperatures are expected ...
Testing rules following high-risk contact eased for vaccinated people
The coronavirus testing policy following a high-risk contact has been eased, meaning a vaccinated person who was in contact with an infected person ...
New measures announced for Belgian schools
Stricter rules are being implemented across a variety of sectors in Belgium to curb the rising number of infections and limit the damage as a result ...
Majority of booster doses should be administered by March 2022
Invitations will be sent out in the following days for the general population in Belgium to receive a coronavirus booster vaccine, and most adults ...
Belgium adopts national plan to combat gender-based violence
Belgium has adopted a National Action plan for the Fight against Gender-Based Violence, which includes more than 200 measures and unites all levels ...
Antwerp cancels Christmas market and New Year’s Eve fireworks
The city of Antwerp has joined other cities including Leuven and Ghent by announcing it is cancelling this year's Christmas market, the end-of-year ...
Pharmaceutical companies looking into vaccines against new variant
Pharmaceutical companies have sprung into action to look into vaccine protection against the new coronavirus variant first detected in South Africa, ...
Belgium imposes entry ban on travellers from southern Africa
Belgium is introducing an entry ban for travellers from several countries in the south of Africa following concerns about a new variant (B.1.1.529) ...
What Ursula did next
BRUSSELS BEHIND THE SCENES • Weekly analysis and untold stories
Nightclub closures, limiting contacts: These rules come into force today
Just over one week after its last meeting, Belgium's Consultative Committee on Friday once again announced a set of new measures to curb the rising ...
Almost 3,500 Covid-19 patients in hospitals as new cases continue to skyrocket
The number of new coronavirus cases in Belgium is continuing to rise, and with it the number of Covid-19 patients who are hospitalised as a result of ...